Page 20 - Andreaf Wainer News Today

Patriot Investment Management Group Inc. increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 13.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,560 shares of the healthcare product maker’s stock after purchasing an additional 416 shares during the quarter. Patriot Investment […]

Bar Harbor Wealth Management lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 142,348 shares of the healthcare product maker’s stock after selling 1,502 shares during the quarter. […]

Patriot Investment Management Group Inc. lifted its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 13.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,560 shares of the healthcare product maker’s stock after purchasing an additional 416 shares during […]

Red Door Wealth Management LLC increased its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,851 shares of the healthcare product maker’s stock after acquiring an additional 313 shares during the quarter. Red […]

Assenagon Asset Management S.A. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 21.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 418,751 shares of the healthcare product maker’s stock after selling 117,176 shares during the period. […]

Assenagon Asset Management S.A. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 21.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 418,751 shares of the healthcare product maker’s stock after selling 117,176 shares during the quarter. Assenagon Asset Management […]

Schechter Investment Advisors LLC grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 11.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 54,929 shares of the healthcare product maker’s stock after purchasing an additional 5,835 shares during the period. Schechter Investment Advisors LLC’s […]

Kaydan Wealth Management Inc. lessened its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,108 shares of the healthcare product maker’s stock after selling 121 shares during the quarter. Kaydan Wealth […]

Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen analysts that are currently covering the firm, Marketbeat reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average twelve-month price […]

Shares of Abbott Laboratories (NYSE:ABT – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month […]